ArticlePloS one2018

Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.

Jana Soukupova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.